ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Kardigan
22.00
+6.00
37.50%
盤後:
22.00
0.0000
0.00%
19:59 EDT
成交量:
584.44萬
成交額:
1.14億
市值:
19.29億
市盈率:
-8.39
高:
23.75
開:
16.25
低:
16.25
收:
16.00
52周最高:
23.75
52周最低:
16.25
股本:
8,767.25萬
流通股本:
2,333.33萬
量比:
- -
換手率:
25.05%
股息:
- -
股息率:
- -
每股收益(TTM):
-2.6230
淨資產收益率:
--
總資產收益率:
--
市淨率:
-6.42
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
異動解讀|Kardigan盤中上漲42.28%,IPO首日獲市場熱捧
行情直击
·
昨天
卡迪根在納斯達克上市首日股價上漲,此前其IPO規模擴大至4億美元
路透中文
·
昨天
異動解讀 | 卡迪根IPO首日盤中大漲5.44%,募資4億美元推動股價上揚
异动解读
·
昨天
美股異動 | Kardigan(KARD.US)登陸美股市場 開盤升逾25%
智通财经
·
昨天
心臟病藥物開發商Kardigan通過規模擴大的美國首次公開募股(IPO)籌集了4億美元
路透中文
·
06/18
明日關注要點——6月18日,星期四
路透中文
·
06/18
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/KARD/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KARD\",,,,,undefined,":{"symbol":"KARD","market":"US","secType":"STK","nameCN":"Kardigan","latestPrice":22,"timestamp":1781812800000,"preClose":16,"halted":0,"volume":5844442,"hourTrading":{"tag":"盘后","latestPrice":22,"preClose":22,"latestTime":"19:59 EDT","volume":49387,"amount":1039648.3023,"timestamp":1781827198381,"change":0,"changeRate":0,"amplitude":0.086818},"delay":0,"changeRate":0.375,"floatShares":23333300,"shares":87672455,"eps":-2.623,"marketStatus":"休市中","change":6,"latestTime":"06-18 16:00:00 EDT","open":16.25,"high":23.75,"low":16.25,"amount":113636875.58236,"amplitude":0.46875,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.623,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"listingDate":1781755200000,"exchange":"NASDAQ","adjPreClose":16,"postHourTrading":{"tag":"盘后","latestPrice":22,"preClose":22,"latestTime":"19:59 EDT","volume":49387,"amount":1039648.3023,"timestamp":1781827198381,"change":0,"changeRate":0,"amplitude":0.086818},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KARD\",,,,,undefined,":{"symbol":"KARD","floatShares":23333300,"roa":"--","roe":"--","lyrEps":0,"shares":87672455,"dividePrice":0,"high":23.75,"amplitude":0.46875,"preClose":16,"low":16.25,"week52Low":16.25,"pbRate":"-6.42","week52High":23.75,"institutionHeld":0,"latestPrice":22,"eps":-2.623,"divideRate":0,"volume":5844442,"delay":0,"ttmEps":-2.623,"open":16.25,"prevYearClose":16,"prevWeekClose":16,"prevMonthClose":16,"prevQuarterClose":16,"fiveDayClose":16,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KARD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KARD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KARD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1123564483","title":"異動解讀|Kardigan盤中上漲42.28%,IPO首日獲市場熱捧","url":"https://stock-news.laohu8.com/highlight/detail?id=1123564483","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123564483?lang=zh_tw&edition=fundamental","pubTime":"2026-06-19 03:47","pubTimestamp":1781812023,"startTime":"0","endTime":"0","summary":"6月19日,Kardigan盘中上涨42.28%,报22.765美元/股,成交额9976.32万美元。消息面上,Kardigan于当日正式登陆纳斯达克市场,以每股16美元的价格发行2500万股,募资约4亿美元,定价位于此前14至16美元发行区间上限,并授予承销商30天内超额配售375万股的选择权。首日交易中股价最高触及21美元上方,市场追捧情绪显著。Kardigan是一家临床阶段精准心血管疗法公司,旗下拥有Danicamtiv、Ataciguat及Tonlamarsen三项后期临床管线,均聚焦当前尚无获批疗法的心血管适应症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644080182","title":"卡迪根在納斯達克上市首日股價上漲,此前其IPO規模擴大至4億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644080182","media":"路透中文","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644080182?lang=zh_tw&edition=fundamental","pubTime":"2026-06-19 00:42","pubTimestamp":1781800951,"startTime":"0","endTime":"0","summary":"卡迪根在纳斯达克上市首日股价上涨,此前其IPO规模扩大至4亿美元路透6月18日 - 周四,心脏病药物开发商卡迪根(Kardigan)旗下 KARD.O 的股票在纳斯达克首日上市时上涨1.6%,此前该公司通过规模扩大的美国首次公开募股(IPO)筹集了4亿美元。(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nL4S42Q1H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115903126","title":"異動解讀 | 卡迪根IPO首日盤中大漲5.44%,募資4億美元推動股價上揚","url":"https://stock-news.laohu8.com/highlight/detail?id=1115903126","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115903126?lang=zh_tw&edition=fundamental","pubTime":"2026-06-19 00:41","pubTimestamp":1781800867,"startTime":"0","endTime":"0","summary":"生物科技公司卡迪根今日盘中大涨5.44%,引起了市场的广泛关注。消息面上,卡迪根成功完成了规模扩大的首次公开募股,以每股16美元的价格发行2500万股,共筹集4亿美元资金,发行价位于目标区间上限。该公司股票于今日在纳斯达克交易所首次上市交易,市场对其首日表现抱有较高期待。公司计划将本次IPO募集资金用于这些药物的临床开发及其他研发活动。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644708021","title":"美股異動 | Kardigan(KARD.US)登陸美股市場 開盤升逾25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644708021","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644708021?lang=zh_tw&edition=fundamental","pubTime":"2026-06-19 00:00","pubTimestamp":1781798400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周四,Kardigan(KARD.US)登陆美股市场,开盘股价涨超25%,报20.1美元。IPO价格为16美元。Kardigan是一家专注于心血管疾病创新疗法研发的临床阶段生物技术公司,致力于开发用于治疗心律失常及其他心脏疾病的新一代精准药物。公司核心产品管线聚焦于调节心脏电生理功能,通过靶向特定离子通道改善异常心律问题,目标是在提升疗效的同时降低传统抗心律失常药物带来的安全性风险。目前,公司多项候选药物仍处于临床开发阶段,尚未实现商业化收入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"美股异动 | Kardigan(KARD.US)登陆美股市场 开盘涨超25%","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644709507","title":"心臟病藥物開發商Kardigan通過規模擴大的美國首次公開募股(IPO)籌集了4億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644709507","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644709507?lang=zh_tw&edition=fundamental","pubTime":"2026-06-18 17:06","pubTimestamp":1781773608,"startTime":"0","endTime":"0","summary":"心脏病药物开发商Kardigan通过规模扩大的美国首次公开募股筹集了4亿美元路透6月18日 - 临床阶段生物技术公司Kardigan周三通过规模扩大的首次公开募股筹集了4亿美元,其股票定价位于目标区间上限,从而 加入了这波寻求进入公开市场的企业浪潮。随着投资者对新股的热情依然高涨,美国IPO市场活动已出现反弹,多个行业的公司正争相上市 。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nL4T42Q0QO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KARD","BK4207","MNSH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644259617","title":"明日關注要點——6月18日,星期四","url":"https://stock-news.laohu8.com/highlight/detail?id=2644259617","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644259617?lang=zh_tw&edition=fundamental","pubTime":"2026-06-18 02:36","pubTimestamp":1781721363,"startTime":"0","endTime":"0","summary":"明日关注要点——6月18日,星期四《今日要闻》是一份通过电子邮件和PDF形式发布的刊物,内容涵盖当日主要新闻、事件、分析及其他专题报导。投资者将密切关注有关消费者信心状况的评论。在美国经济方面,截至6月13日当周,美国首次申请失业救济人数预计将从前一周的22.9万小幅降至22.5万。继4月份上涨2%之后,上月价格预计上涨1.8%。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nL4T42P1LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648001328.SGD","LU0345770308.USD","BK4532","LU0345770993.USD","LU1201861249.SGD","LU0130517989.USD","BK4588","LU0312595415.SGD","LU0980610538.SGD","KARD","BK4559","LU0302445910.USD","LU0130102774.USD","BK4504","LU1989763427.SGD","BK4533","LU2275660780.HKD","LU1989763690.USD","BK4585","LU0477156953.USD","BK4113","KR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}